Lung cancer is one of the most common malignant tumors in the world, and it is also the leading cause of cancer-related death. Non-small cell lung cancer (NSCLC) is the main type of lung cancer, and epidermal growth factor receptor (EGFR) gene mutation is a common driving gene for NSCLC. The first and second generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are effective in the treatment of NSCLC with EGFR mutation-positive, but they are prone to drug resistance caused by T790M mutation. Almonertinib is a noval and irreversible third generation EGFR-TKI independently developed in China. It has high selectivity to EGFR sensitization and T790M drug resistance mutation and also has good central nervous system activity and tolerance. In this paper, we reviewed the mechanism of action, pharmacodynamics, pharmacokinetics, clinical research and combination therapy of almonertinib, to provide a reference for clinical application.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |